Abstract:Recently, heterozygous de novo mutations in have been reported to underlie severe early-onset epileptic encephalopathy. In one male presenting with epileptic seizures and visual impairment, we identified a novel homozygous splicing variant in (c.1421 + 1G > C) by using exome sequencing. Functional studies on cDNA level confirmed a consecutive loss of function. Our findings suggest that not only de novo mutations but also biallelic variants in can cause epilepsy and that there is an additional autosomal recessi… Show more
“…In this study, we show that a genetic perturbation of the excitatory glutamate system leads to profound functional alterations in neuronal and astroglial networks, leading to spontaneous and light-induced seizures. Our results are in line with the earlier observations associating EAAT2 malfunctions to seizures in mice and humans (Epi4K Consortium et al, 2013;Epi4K Consortium, 2016;Guella et al, 2017;Petr et al, 2015;Stergachis et al, 2019;Tanaka et al, 1997;Wagner et al, 2018), and with findings on abnormal motor behavior in the zebrafish techno trousers (tnt) mutant defective in EAAT2a (McKeown et al, 2012). Firstly, homozygous mutations of the astroglial eaat2a in zebrafish resemble a form of DEE present in human epilepsy patients with de novo mutations in the orthologous gene (EAAT2 = SLC1A2) (Epi4K Consortium et al, 2013;Epi4K Consortium, 2016;Guella et al, 2017).…”
Astroglial excitatory amino acid transporter 2 (EAAT2, GLT-1, and SLC1A2) regulates the duration and extent of neuronal excitation by removing glutamate from the synaptic cleft. Hence, an impairment in EAAT2 function could lead to an imbalanced brain network excitability. Here, we investigated the functional alterations of neuronal and astroglial networks associated with the loss of function in the astroglia predominant eaat2a gene in zebrafish. We observed that eaat2a À/À mutant zebrafish larvae display recurrent spontaneous and light-induced seizures in neurons and astroglia, which coincide with an abrupt increase in extracellular glutamate levels. In stark contrast to this hyperexcitability, basal neuronal and astroglial activity was surprisingly reduced in eaat2a À/À mutant animals, which manifested in decreased overall locomotion. Our results reveal an essential and mechanistic contribution of EAAT2a in balancing brain excitability, and its direct link to epileptic seizures.
“…In this study, we show that a genetic perturbation of the excitatory glutamate system leads to profound functional alterations in neuronal and astroglial networks, leading to spontaneous and light-induced seizures. Our results are in line with the earlier observations associating EAAT2 malfunctions to seizures in mice and humans (Epi4K Consortium et al, 2013;Epi4K Consortium, 2016;Guella et al, 2017;Petr et al, 2015;Stergachis et al, 2019;Tanaka et al, 1997;Wagner et al, 2018), and with findings on abnormal motor behavior in the zebrafish techno trousers (tnt) mutant defective in EAAT2a (McKeown et al, 2012). Firstly, homozygous mutations of the astroglial eaat2a in zebrafish resemble a form of DEE present in human epilepsy patients with de novo mutations in the orthologous gene (EAAT2 = SLC1A2) (Epi4K Consortium et al, 2013;Epi4K Consortium, 2016;Guella et al, 2017).…”
Astroglial excitatory amino acid transporter 2 (EAAT2, GLT-1, and SLC1A2) regulates the duration and extent of neuronal excitation by removing glutamate from the synaptic cleft. Hence, an impairment in EAAT2 function could lead to an imbalanced brain network excitability. Here, we investigated the functional alterations of neuronal and astroglial networks associated with the loss of function in the astroglia predominant eaat2a gene in zebrafish. We observed that eaat2a À/À mutant zebrafish larvae display recurrent spontaneous and light-induced seizures in neurons and astroglia, which coincide with an abrupt increase in extracellular glutamate levels. In stark contrast to this hyperexcitability, basal neuronal and astroglial activity was surprisingly reduced in eaat2a À/À mutant animals, which manifested in decreased overall locomotion. Our results reveal an essential and mechanistic contribution of EAAT2a in balancing brain excitability, and its direct link to epileptic seizures.
“…In the case of the latter group, this may be the result of different variant effects. For example, recessive disease might result from two loss of function variants, whereas dominant disease may result from a single gain of function variant in the same gene 11–13 …”
Section: Resultsmentioning
confidence: 99%
“…For example, recessive disease might result from two loss of function variants, whereas dominant disease may result from a single gain of function variant in the same gene. 11 , 12 , 13 …”
Section: Resultsmentioning
confidence: 99%
“…For example, recessive disease might result from two loss of function variants, whereas dominant disease may result from a single gain of function variant in the same gene. [11][12][13] Almost 90% of the curated monogenic genes have been associated with a DEE phenotype (n = 825/926 total). By comparison, just 5% of all epilepsy genes were associated with a GGE and/or focal epilepsy phenotype (n = 45/926).…”
Section: Monogenic Epilepsy Genes and Insightsmentioning
Objective: "How many epilepsy genes are there?" is a frequently asked question.We sought to (1) provide a curated list of genes that cause monogenic epilepsies, and (2) compare and contrast epilepsy gene panels from multiple sources.
Methods:We compared genes included on the epilepsy panels (as of July 29, 2022
“…Patients with WAGR may have undiagnosed epilepsy or unrecognized seizures, as a patient affected by WAGR with obesity was described with signs of rolandic epilepsy of childhood demonstrated by electroencephalogram, despite the absence of seizures ( 59 ). Further research is needed to explore potential mechanisms leading to seizures in patients with WAGR syndrome, as a variety involving the common WAGR genes and SLC1A2 and ELP4 genes have been suggested ( 24 , 60 , 61 ).…”
WAGR syndrome is a rare genetic disorder characterized by Wilms tumor, Aniridia, Genitourinary anomalies, and Range of developmental delays. In addition to the classic features, patients affected by WAGR syndrome can develop obesity and kidney failure, and a wide variety of non-classical manifestations have also been described. This suggests that a broader phenotypic spectrum beyond the classic syndrome exists and here we demonstrate that spectrum using data from the WAGR Syndrome Patient Registry. In the present study, we collected information from 91 individuals enrolled in the registry to explore self-reported health issues in this patient population. A wide variety of common clinical issues not classically associated with the disorder were found, prompting the redefinition from WAGR syndrome to WAGR spectrum disorder to incorporate the phenotypic variations that occur. A comprehensive care management approach is needed to address the wide range of clinical issues and we propose a care model for patients affected by WAGR spectrum disorder. Further research is needed to solidify the breath of the phenotype and confirm the observations in this study to advance individualized patient care in this population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.